Highlights and Quick Summary
- Equity Repurchase (Preffered, Net) for the quarter ending December 31, 2013 was $0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Equity Repurchase (Preffered, Net) decreased by -100.0%
- Annual Equity Repurchase (Preffered, Net) for 2013 was $150 Million (a 98.52% increase from previous year)
- Twelve month Equity Repurchase (Preffered, Net) ending December 31, 2013 was $150 Million (a 0.0% decrease compared to previous quarter)
Trailing Equity Repurchase (Preffered, Net) for the last four month:
| 31 Dec '13 | 30 Sep '13 | 30 Jun '13 | — |
|---|---|---|---|
| $150 Million | $150 Million | $201 Million | — |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Equity Repurchase (Preffered, Net) of Precigen, Inc.
Most recent Equity Repurchase (Preffered, Net)of PGEN including historical data for past 10 years.Interactive Chart of Equity Repurchase (Preffered, Net) of Precigen, Inc.
Precigen, Inc. Equity Repurchase (Preffered, Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2013 | $0.0 | $0.0 | $85.59 | $64.41 | $150.0 |
| 2012 | $0.0 | $50.56 | – | – | $75.56 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology